Search

everythinglearnresearchcommunity

for

Search:↓

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

The mouse model showed defects in adult stem cell maintenance related to Hutchinson-Gilford progeria syndrome.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Prostaglandins don't genetically contribute to hair loss.

Minoxidil can reduce functions related to androgen receptors.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

Mutations in mitochondrial DNA might significantly contribute to the development of Polycystic Ovarian Syndrome.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Hair loss needs more research for better treatments.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

Male pattern baldness is partly caused by specific genes, but most genetic factors are still unknown.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

A male with aromatase deficiency improved bone health with estradiol treatment.

New mutations in the EBP gene cause CDPX2, affecting bones, skin, eyes, and hair, with females generally less affected than males.

A gene mutation causes a rare hereditary hair loss, offering potential for new treatments.